 |
antihemophilic factor (recombinant), porcine sequence |
|---|---|
| Trade Name | Obizur |
| Orphan Indication | Treatment and prevention of episodic bleeding in patients with inhibitor antibodies to human coagulation factor VIII |
| USA Market Approval | USA |
| USA Designation Date | 2004-03-16 00:00:00 |
| Sponsor | Baxalta US, Inc.;1 Baxter Way, Mail Box Number 1A-3;Westlake Village, California, 91362 |
